Emergency Number

Investors

  •  Dr. Vikram Shah – Chairman & Managing Director, Shalby Limited at Edelweiss India Conference (Feb’18):

 

  • Dr. Vikram Shah – Chairman & Managing Director, Shalby Limited at IIFL Enterprising India IX-2018 (Feb’18):

Statement of Investor Complaints – Q4 FY 2017-18
Share Capital Audit – 31-03-2018
Compliance Certificate under Reg. 7(3) of LODR
Press Release – MoU with Sen Sok Intl Hospital, Cambodia
Certificate under Regulation 40(10) of SEBI LODR
Joint Replacement Surgeries under Mukhyamantri Amrutam Yojana
Change in CIN
Schedule of Investor / Analyst Meet
Schedule of Investor / Analyst Meet – 27-04-2018
Utilization of Issue Proceeds – Q4 FY 2017-18
Utilization of Issue Proceeds – Q4 FY 2017-18
Intimation Conference Call
Intimation Appointment of CDSL as designated depository
Collaboration with Berkeley Health Education
Investor/Analyst meeting with Motilal Oswal Securities Limited
Investors meet/UBS India- Midcap conference
Resignation of Chief Executive Officer of the Company
Intimation Analyst meet HDFC Securities 26-06-2018
Updates relating to resignation of CEO
Man of the Year Award – Dr. Vikram Shah
Intimation Analyst meet – 26-06-2018
Intimation Analyst meet - 27-06-2018
Intimation Analyst meet - 02-07-2018
Intimation Analyst meet – 06-07-2018
Intimation Liver Disease and Transplantation
Karvy Reconciliation Report
Investor Grievance report
Utilization of Issue Proceeds – Q1 FY 2018-19
 Intimation of AGM
 Intimation of Book closure
 AGM Notice & Annual Report 2017-18
 Newspaper Ad. AGM, Book closure & E-voting
 Outcome of AGM
 Voting Results
 Shalby Press Release - Ovarian Mass Removal Jaipur
 Credit Rating ICRA Reg 30 LODR
 Reg 30 Orthotrends 2018 Chandigarh
 Intimation under Regulation 30 of SEBI LODR-concall with Edelweiss
 Investor Grievance Report Q2 FY 2018-19
 Share Capital Audit Q2 FY 2018-19
 Compliance Certificate 7(3) – 30-09-2018
 Certificate under Regulation 40(10) of SEBI LODR –H1 FY 2018-19
 Pre Accreditation Entry level NABH at Shalby Surat
 Intimation for Conference call
 Submission of newspaper AD – Notice of Board Meeting
 Utilization of Issue Proceeds - Q2 FY 2018-19
 Pre-Accreditation Entry level NABH at Shalby Naroda

Financial Year Q1 Q2 Q3 Q4
2017-18
2018-19

 

Registered & Corporate Office

Shalby Limited

Opposite Karnawati Club,

Sarkhej Gandhinagar Highway,

Near Prahlad Nagar Garden,

Ahmedabad – 380 015, Gujarat, India

Phone: +91 79 4020 3000

Fax :+91 79 4020 3120

CIN : L85110GJ2004PLC044667

 

Listed at NSE & BSE

Listing Date    December 15, 2017

Scrip Code : NSE – SHALBY

BSE – 540797

 

ISIN     INE597J01018

Face Value of Shares  ` 10

Outstanding Shares 108,009,770

Financial Year ending  March 31 of every year

Grievance Redressal

The Shareholders may forward their queries/grievances to the Company at the following address :

Compliance Officer :

Mr. Jayesh Patel

Company Secretary and Compliance Officer

Email : Companysecretary@shalby.in

Tel. No : +91 79 4020 3000

Fax No : +91 79 4020 3120

Website : www.shalby.org

Registrar & Transfer Agent

Karvy Computershare Private Limited

Unit : Shalby Limited

Karvy Selenium, Tower B,

Plot 31 – 32, Gacchibowli

Financial District, Nanakramguda,

Hyderabad – 500 032, Telangana, India

Tel: +91 40 6716 2222

Fax: +91 40 2343 1551

Investor Grievance E-mail: einward.ris@karvy.com

News paper Ad – ET A’bad (Eng + Guj)

Financial Year Q1 Q2 Q3 Q4
Result Transcript Result Transcript Result Transcript Result Transcript
2017-18
2018-19

 

 

Financial Year Q1 Q2 Q3 Q4
2017-18
2018-19
Financial Year Q1 Q2 Q3 Q4
2017-18  
2018-19
Annual Reports
2016-17 2017-18
Shalby Limited
Subsidiary Companies
Shalby (Kenya) Limited
Yogeshwar Healthcare Ltd.
Vrundavan Shalby Hospitals Ltd.
Shalby International Ltd.
Griffin Mediquip LLP
Please wait...

Subscribe to our newsletter

Want to be notified when our article is published? Enter your email address and name below to be the first to know.